Report cover image

Oral Live Attenuated Rotavirus Vaccine Industry Research Report 2025

Publisher APO Research, Inc.
Published Jul 07, 2025
Length 112 Pages
SKU # APRC20261380

Description

Summary

According to APO Research, the global Oral Live Attenuated Rotavirus Vaccine market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Oral Live Attenuated Rotavirus Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Oral Live Attenuated Rotavirus Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Oral Live Attenuated Rotavirus Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Oral Live Attenuated Rotavirus Vaccine include Merck Sharp & Dohme, Lanzhou Biological Products Research Institute, GSK and Bharat Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral Live Attenuated Rotavirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Live Attenuated Rotavirus Vaccine.

The report will help the Oral Live Attenuated Rotavirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.



The Oral Live Attenuated Rotavirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Live Attenuated Rotavirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Oral Live Attenuated Rotavirus Vaccine Segment by Company

Merck Sharp & Dohme
Lanzhou Biological Products Research Institute
GSK
Bharat Biotech
Oral Live Attenuated Rotavirus Vaccine Segment by Type

Monovalent Vaccines
Combination Vaccines
Oral Live Attenuated Rotavirus Vaccine Segment by Application

Hospitals and Clinics
Vaccination Sites
Oral Live Attenuated Rotavirus Vaccine Segment by Region


North America
United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Colombia
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Live Attenuated Rotavirus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Live Attenuated Rotavirus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Live Attenuated Rotavirus Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Oral Live Attenuated Rotavirus Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Oral Live Attenuated Rotavirus Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Oral Live Attenuated Rotavirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

112 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Oral Live Attenuated Rotavirus Vaccine Market Size (2020-2031)
2.2.2 Global Oral Live Attenuated Rotavirus Vaccine Sales (2020-2031)
2.2.3 Global Oral Live Attenuated Rotavirus Vaccine Market Average Price (2020-2031)
2.3 Oral Live Attenuated Rotavirus Vaccine by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Monovalent Vaccines
2.3.3 Combination Vaccines
2.4 Oral Live Attenuated Rotavirus Vaccine by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Hospitals and Clinics
2.4.3 Vaccination Sites
3 Market Competitive Landscape by Manufacturers
3.1 Global Oral Live Attenuated Rotavirus Vaccine Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Oral Live Attenuated Rotavirus Vaccine Sales (K Units) of Manufacturers (2020-2025)
3.3 Global Oral Live Attenuated Rotavirus Vaccine Revenue of Manufacturers (2020-2025)
3.4 Global Oral Live Attenuated Rotavirus Vaccine Average Price by Manufacturers (2020-2025)
3.5 Global Oral Live Attenuated Rotavirus Vaccine Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Oral Live Attenuated Rotavirus Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Oral Live Attenuated Rotavirus Vaccine, Product Type & Application
3.8 Global Manufacturers of Oral Live Attenuated Rotavirus Vaccine, Established Date
3.9 Global Oral Live Attenuated Rotavirus Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Merck Sharp & Dohme
4.1.1 Merck Sharp & Dohme Company Information
4.1.2 Merck Sharp & Dohme Business Overview
4.1.3 Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Product Portfolio
4.1.5 Merck Sharp & Dohme Recent Developments
4.2 Lanzhou Biological Products Research Institute
4.2.1 Lanzhou Biological Products Research Institute Company Information
4.2.2 Lanzhou Biological Products Research Institute Business Overview
4.2.3 Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Product Portfolio
4.2.5 Lanzhou Biological Products Research Institute Recent Developments
4.3 GSK
4.3.1 GSK Company Information
4.3.2 GSK Business Overview
4.3.3 GSK Oral Live Attenuated Rotavirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.3.4 GSK Oral Live Attenuated Rotavirus Vaccine Product Portfolio
4.3.5 GSK Recent Developments
4.4 Bharat Biotech
4.4.1 Bharat Biotech Company Information
4.4.2 Bharat Biotech Business Overview
4.4.3 Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Product Portfolio
4.4.5 Bharat Biotech Recent Developments
5 Global Oral Live Attenuated Rotavirus Vaccine Market Scenario by Region
5.1 Global Oral Live Attenuated Rotavirus Vaccine Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Oral Live Attenuated Rotavirus Vaccine Sales by Region: 2020-2031
5.2.1 Global Oral Live Attenuated Rotavirus Vaccine Sales by Region: 2020-2025
5.2.2 Global Oral Live Attenuated Rotavirus Vaccine Sales by Region: 2026-2031
5.3 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Region: 2020-2031
5.3.1 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Region: 2020-2025
5.3.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Region: 2026-2031
5.4 North America Oral Live Attenuated Rotavirus Vaccine Market Facts & Figures by Country
5.4.1 North America Oral Live Attenuated Rotavirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Oral Live Attenuated Rotavirus Vaccine Sales by Country (2020-2031)
5.4.3 North America Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Oral Live Attenuated Rotavirus Vaccine Market Facts & Figures by Country
5.5.1 Europe Oral Live Attenuated Rotavirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Oral Live Attenuated Rotavirus Vaccine Sales by Country (2020-2031)
5.5.3 Europe Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Oral Live Attenuated Rotavirus Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Oral Live Attenuated Rotavirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Oral Live Attenuated Rotavirus Vaccine Sales by Country (2020-2031)
5.6.3 Asia Pacific Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Oral Live Attenuated Rotavirus Vaccine Market Facts & Figures by Country
5.7.1 South America Oral Live Attenuated Rotavirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Oral Live Attenuated Rotavirus Vaccine Sales by Country (2020-2031)
5.7.3 South America Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.7.7 Colombia
5.8 Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales by Country (2020-2031)
5.8.3 Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Oral Live Attenuated Rotavirus Vaccine Sales by Type (2020-2031)
6.1.1 Global Oral Live Attenuated Rotavirus Vaccine Sales by Type (2020-2031) & (K Units)
6.1.2 Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2020-2031)
6.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2020-2031)
6.2.1 Global Oral Live Attenuated Rotavirus Vaccine Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2020-2031)
6.3 Global Oral Live Attenuated Rotavirus Vaccine Price by Type (2020-2031)
7 Segment by Application
7.1 Global Oral Live Attenuated Rotavirus Vaccine Sales by Application (2020-2031)
7.1.1 Global Oral Live Attenuated Rotavirus Vaccine Sales by Application (2020-2031) & (K Units)
7.1.2 Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2020-2031)
7.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2020-2031)
7.2.1 Global Oral Live Attenuated Rotavirus Vaccine Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2020-2031)
7.3 Global Oral Live Attenuated Rotavirus Vaccine Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Oral Live Attenuated Rotavirus Vaccine Value Chain Analysis
8.1.1 Oral Live Attenuated Rotavirus Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Oral Live Attenuated Rotavirus Vaccine Production Mode & Process
8.2 Oral Live Attenuated Rotavirus Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Oral Live Attenuated Rotavirus Vaccine Distributors
8.2.3 Oral Live Attenuated Rotavirus Vaccine Customers
9 Global Oral Live Attenuated Rotavirus Vaccine Analyzing Market Dynamics
9.1 Oral Live Attenuated Rotavirus Vaccine Industry Trends
9.2 Oral Live Attenuated Rotavirus Vaccine Industry Drivers
9.3 Oral Live Attenuated Rotavirus Vaccine Industry Opportunities and Challenges
9.4 Oral Live Attenuated Rotavirus Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.